Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00632021 · ClinicalTrials.gov registry record · NA
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
A NA study of Heart Failure and Acute Coronary Syndrome, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 862
- Enrollment target
- 2
- Study locations
NCT00632021: Completed NA study of Heart Failure and Acute Coronary Syndrome, sponsored by Vanderbilt University Medical Center.
NCT00632021 is a NA study of Heart Failure and Acute Coronary Syndrome that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 862 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00632021, a NA study of Heart Failure and Acute Coronary Syndrome, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 862 participants
- Enrollment target
- 2
- Study locations
Study Summary
Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focused program that provides educational assistance from pharmacists at the time of hospital discharge to people hospitalized with heart problems.
Primary Outcome
Number of clinically important medication errors per patient
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist Intervention for Low-Literacy in Cardiovascular Disease
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 862 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT00632021 record still lists
NCT00632021 is an interventional study that assigns participants to a tested intervention. The registered 862 participants enrollment target is mid-sized for trials with a published cap, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist Intervention for Low-Literacy in Cardiovascular Disease is the first listed.
NCT00632021 reports a single indexed study location in Massachusetts, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00632021 about?
NCT00632021 is a clinical study titled "Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)". Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focuse...
What is the current status of trial NCT00632021?
This trial is currently completed. It is a NA study. The enrollment target is 862 participants. The study started on 2008-05. Estimated completion is 2012-03.
What conditions does trial NCT00632021 study?
This clinical trial studies the following conditions: Heart Failure, Acute Coronary Syndrome.
What interventions are being tested in trial NCT00632021?
The interventions under investigation include: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease (BEHAVIORAL).
Who is sponsoring clinical trial NCT00632021?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00632021 being conducted?
This trial has 2 study locations across Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00632021's enrollment target sits among peer trials
862 75th of 397 higher than 323 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05914116 · 862 participants · Phase 1
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- NCT06256588 · 864 participants · Phase 3
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- NCT06527794 · 864 participants · NA
Remote Hypertension Management for Black Patients
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia